212 related articles for article (PubMed ID: 35867408)
1. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
[TBL] [Abstract][Full Text] [Related]
2. Fecal Mycobiota Combined With Host Immune Factors Distinguish Clostridioides difficile Infection From Asymptomatic Carriage.
Cao Y; Wang L; Ke S; Villafuerte Gálvez JA; Pollock NR; Barrett C; Sprague R; Daugherty K; Xu H; Lin Q; Yao J; Chen Y; Kelly CP; Liu YY; Chen X
Gastroenterology; 2021 Jun; 160(7):2328-2339.e6. PubMed ID: 33684427
[TBL] [Abstract][Full Text] [Related]
3. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
[TBL] [Abstract][Full Text] [Related]
4. Integrated Meta-omics Reveals a Fungus-Associated Bacteriome and Distinct Functional Pathways in Clostridioides difficile Infection.
Stewart DB; Wright JR; Fowler M; McLimans CJ; Tokarev V; Amaniera I; Baker O; Wong HT; Brabec J; Drucker R; Lamendella R
mSphere; 2019 Aug; 4(4):. PubMed ID: 31462412
[TBL] [Abstract][Full Text] [Related]
5. Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea.
Villafuerte Gálvez JA; Pollock NR; Alonso CD; Chen X; Xu H; Wang L; White N; Banz A; Miller M; Daugherty K; Gonzalez-Luna AJ; Barrett C; Sprague R; Garey KW; Kelly CP
Clin Infect Dis; 2023 Feb; 76(3):e1467-e1475. PubMed ID: 35906836
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota composition in health-care facility-and community-onset diarrheic patients with Clostridioides difficile infection.
Herrera G; Vega L; Patarroyo MA; Ramírez JD; Muñoz M
Sci Rep; 2021 May; 11(1):10849. PubMed ID: 34035404
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of Clostridioides difficile infection in hospitalized patients with new diarrhea: A retrospective cohort study.
Demir KK; Cheng MP; Lee TC
PLoS One; 2018; 13(12):e0207128. PubMed ID: 30517148
[TBL] [Abstract][Full Text] [Related]
10. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
11. Characterization of the gut microbiome of patients with
Vázquez-Cuesta S; Villar L; García NL; Fernández AI; Olmedo M; Alcalá L; Marín M; Muñoz P; Bouza E; Reigadas E
Front Cell Infect Microbiol; 2023; 13():1130701. PubMed ID: 37124040
[TBL] [Abstract][Full Text] [Related]
12. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
13. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
14.
Battaglioli EJ; Hale VL; Chen J; Jeraldo P; Ruiz-Mojica C; Schmidt BA; Rekdal VM; Till LM; Huq L; Smits SA; Moor WJ; Jones-Hall Y; Smyrk T; Khanna S; Pardi DS; Grover M; Patel R; Chia N; Nelson H; Sonnenburg JL; Farrugia G; Kashyap PC
Sci Transl Med; 2018 Oct; 10(464):. PubMed ID: 30355801
[TBL] [Abstract][Full Text] [Related]
15. Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection.
Lin CY; Cheng HT; Kuo CJ; Lee YS; Sung CM; Keidan M; Rao K; Kao JY; Hsieh SY
Microbiol Spectr; 2022 Aug; 10(4):e0048622. PubMed ID: 35863023
[TBL] [Abstract][Full Text] [Related]
16. Bacterial and Fungal Microbiota Changes Distinguish C. difficile Infection from Other Forms of Diarrhea: Results of a Prospective Inpatient Study.
Sangster W; Hegarty JP; Schieffer KM; Wright JR; Hackman J; Toole DR; Lamendella R; Stewart DB
Front Microbiol; 2016; 7():789. PubMed ID: 27252696
[TBL] [Abstract][Full Text] [Related]
17. Hospitalized patients with diarrhea: Rate of Clostridioides difficile infection underdiagnosis and drivers of clinical suspicion.
Cataldo MA; Granata G; D'Arezzo S; Tonziello G; Vulcano A; De Giuli C; Meledandri M; Di Caro A; Petrosillo N
Anaerobe; 2021 Aug; 70():102380. PubMed ID: 33971317
[TBL] [Abstract][Full Text] [Related]
18. 2'-Fucosyllactose inhibits proliferation of
Wiese M; Schuren FHJ; Smits WK; Kuijper EJ; Ouwens A; Heerikhuisen M; Vigsnaes L; van den Broek TJ; de Boer P; Montijn RC; van der Vossen JMBM
Front Cell Infect Microbiol; 2022; 12():991150. PubMed ID: 36389156
[TBL] [Abstract][Full Text] [Related]
19. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection.
Herrera G; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
Microbiol Spectr; 2022 Oct; 10(5):e0050222. PubMed ID: 36154277
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Clinical Severity With Stool Microbiome Changes in Clostridioides difficile Infection.
Castañeda-Mogollón D; Doolan CP; Toppings NB; Amarasekara R; Tran TA; Pillai DR
Arch Pathol Lab Med; 2023 Jul; 147(7):774-785. PubMed ID: 36308712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
